Amytis Towfighi
Amytis Towfighi is a renowned neurologist and medical researcher specializing in stroke prevention and recovery. She is currently serving as the Chief of Neurology at the Los Angeles County + University of Southern California (LAC+USC) Medical Center.
Early Life and Education[edit | edit source]
Amytis Towfighi was born and raised in the United States. She pursued her undergraduate studies at the University of California, Berkeley, where she majored in Molecular and Cell Biology. She then attended the University of California, San Francisco (UCSF) for her medical degree. Following her graduation, she completed her residency in Neurology at the University of California, Los Angeles (UCLA).
Career[edit | edit source]
After completing her residency, Towfighi joined the faculty at the University of Southern California (USC) as a professor of Neurology. She has since become the Chief of Neurology at the LAC+USC Medical Center. Her research primarily focuses on stroke prevention and recovery, with a particular emphasis on reducing disparities in stroke care.
Towfighi has published numerous peer-reviewed articles in prestigious medical journals. Her work has significantly contributed to the understanding of stroke prevention and recovery, and she is recognized as a leading expert in her field.
Research[edit | edit source]
Towfighi's research focuses on understanding the disparities in stroke care and outcomes. She has conducted several studies investigating the factors that contribute to these disparities, including socioeconomic status, race, and access to healthcare. Her work has led to the development of strategies to improve stroke prevention and recovery, particularly in underserved populations.
Awards and Recognition[edit | edit source]
Throughout her career, Towfighi has received numerous awards and recognition for her contributions to neurology and stroke research. She is a member of several professional organizations, including the American Academy of Neurology and the American Stroke Association.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
